Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapy.

Ng KW., Boumelha J., Enfield KSS., Almagro J., Cha H., Pich O., Karasaki T., Moore DA., Salgado R., Sivakumar M., Young G., Molina-Arcas M., de Carné Trécesson S., Anastasiou P., Fendler A., Au L., Shepherd STC., Martínez-Ruiz C., Puttick C., Black JRM., Watkins TBK., Kim H., Shim S., Faulkner N., Attig J., Veeriah S., Magno N., Ward S., Frankell AM., Al Bakir M., Lim EL., Hill MS., Wilson GA., Cook DE., Birkbak NJ., Behrens A., Yousaf N., Popat S., Hackshaw A., TRACERx Consortium ., CAPTURE Consortium ., Hiley CT., Litchfield K., McGranahan N., Jamal-Hanjani M., Larkin J., Lee S-H., Turajlic S., Swanton C., Downward J., Kassiotis G.

DOI

10.1038/s41586-026-10104-7

Type

Journal article

Publication Date

2026-01-01T00:00:00+00:00

Volume

649

Addresses

Retroviral Immunology Laboratory, The Francis Crick Institute, London, UK.

Keywords

TRACERx Consortium, CAPTURE Consortium

Permalink More information Close